Wound Assessment Tool
OtherA set of questions relating to the symptoms of wound infection
NCT Number: NCT02704897
This study aims to evaluate if a smartphone-delivered tool can help assess for wound infections, and if this improves access to care and results in earlier treatment. Participants will be randomised to one of two groups. The intervention group will receive the smartphone-delivered wound assessment tool (SWAT), to access if they have concerns about their wound. The trial period is 30 days.
Looking for future studies?
Notify Me16 year and older
All sexes
Interventional
Not applicable
Royal Infirmary Edinburgh, Edinburgh, United Kingdom
Surgical site infection (SSI) is defined by the Centre for Disease Control and Prevention (CDC) as an infection in the skin and soft tissues of a surgical wound, within 30 days of the operation. It is a common problem, and complicates 2-10% of general surgery operations. The majority of cases are diagnosed outside of hospital and can be treated with oral antibiotics.
Interest in the use of technology in medicine is increasing, with the potential that more advanced technology will help facilitate communication between clinicians and patients, aid in the assessment of patients, and improve clinical decision making. Over two-thirds of people now own smartphones, and regularly use them to access the internet. The investigators wish to use a smartphone delivered questionnaire to help assess SSI and see if this improves access to care and time to treatment.
The investigators will be recruiting emergency surgery patients with smartphones at the Royal Infirmary and Western General Hospitals in Edinburgh.
Participants will be divided into two groups. One group will receive the wound assessment tool, if they are concerned about their wound, they can use the tool to answer a series of questions. If their answers suggest SSI, a clinician will contact them to advise further assessment and treatment. The participants will also be asked to respond to the tool three times during the trial (to collect responses from those without symptoms), and upload photos of their wounds to a secure database.
The second group of participants will receive normal post-operative care.
After 30 days, participants will have a follow-up consultation, to determine if they have had a wound infection (this can be via telephone or face-to-face, according to participant preference). They will also answer questions about their experience of the study, and use of services.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A set of questions relating to the symptoms of wound infection
Time frame: Outcome assessed at 30 day follow-up
Measured in days from surgery to commencing antibiotic treatment
Time frame: Assessed at 30 day follow-up
Number of attendances at General Practice (GP) and Accident and Emergency (A&E).
Time frame: Assessed at 30 day follow-up
How long in days between experiencing first symptom and being reviewed by A&E, GP or surgical team
University of Edinburgh
Other
Can a Smartphone-delivered Tool Facilitate the Assessment of Surgical Site Infection, and Result in Earlier Treatment? A Randomized-controlled Trial in Emergency Surgery Patients.
Acronym: TWIST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04411199
Abdominal Surgery, Colon Surgery
Augusta, Georgia, United States
View Trial DetailsNCT04366440
Infections, Pathologic Processes
St. Petersburg, Florida, United States
View Trial DetailsNCT06108791
Infections, Pathologic Processes
Asyut, Egypt
View Trial DetailsNCT02734134
Infections, Pathologic Processes
Chicago, Illinois, United States
View Trial Details